Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines

References

• Sawyers C L, Denny C T, Witte O N. Leukemia and the disruption of normal Hematopoiesis. Cell 1991; 64: 337–342
   PubMed Web of Science ®Google Scholar
• Lowenberg B, Downing J R, Burnett A. Acute myeloid leukemia. New England Journal of Medicine 1999; 341: 1051–1062
   PubMed Web of Science ®Google Scholar
• Lichtman M A. Acute myelogenous leukemia. William's hematology. 5th ed, E Beutler, M A Lichtman, B S Coller, T J Kipps. McGraw-Hill Inc, NewYork 1995; 272–298
   Google Scholar
• Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994; 367: 645–647
   PubMed Web of Science ®Google Scholar
• Haase D, Feuring-Buske M, Konemann S. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood 1995; 86: 2906–2911
   PubMed Web of Science ®Google Scholar
• Sutherland H J, Blair A, Zapf R W. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood 1996; 87: 4754–4759
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick J E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997; 3: 730–734
   PubMed Web of Science ®Google Scholar
• Blair A, Hogge D E, Ailles L E, Lansdorp P M, Sutherland H J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 1997; 89: 3104–3112
   PubMed Web of Science ®Google Scholar
• Blair A, Sutherland H J. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Experimental Hematology 2000; 28: 660–671
   PubMed Web of Science ®Google Scholar
• Costello R T, Mallet F, Gaugler B, Sainty D, Arnoulet C, Gastaut J -A, Olive D. Human acute myeloid leukemia CD34+/CD38− progenitor cells have decreased sensitivity to chemotherapy and Fas-Induced apoptosis, reduced immunogenicity and impaired dendritic cell transformation capacities. Cancer Reseaarch 2000; 60: 4403–4411
   PubMed Web of Science ®Google Scholar
• Young D, Wagner K, Griffin J D. Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia. Journal of Clinical Investigations 1987; 79: 100–105
   PubMed Web of Science ®Google Scholar
• Rogers S Y, Bradbury D, Kozlowski R, Russell N H. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. Experiemental Hematology 1994; 22: 593–598
   PubMed Web of Science ®Google Scholar
• Nara N, McCulloch E A. The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia. Blood 1985; 65: 1484–1493
   PubMed Web of Science ®Google Scholar
• Miyauchi J, Kelleher C A, Wong G G, Yang Y C, Clark S C, Minkin S, et al. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3 and CSF-1 on leukemic blast cells in suspension culture. Leukemia 1988; 2: 382–387
   PubMed Web of Science ®Google Scholar
• Oster W, Mertelsmann R, Herrmann F. Role of colony-stimulating factors in the biology of acute myelogenous leukemia. International Journal of Cell Cloning 1989; 7: 13–29
   PubMedGoogle Scholar
• Carlo-Stella C, Mangoni L, Almici C, Frassoni F, Fiers W, Rizzoli V. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors. Leukemia 1990; 4: 561–566
   PubMed Web of Science ®Google Scholar
• Mayani H, Shen S, Guilbert L J, Clark S C, Sych I, Janowska-Wieczorek A. Effect of rhCSF-1 on human hemopoiesis in long-term cultures from patients with acute myelogenous leukemia. Leukemia 1991; 5: 8–13
   PubMed Web of Science ®Google Scholar
• Montesinos J J, Sánchez-Valle E, Miranda-Peralta E, Gutiérrez-Romero M, Mayani H. Effect of rhGM-CSF on the kinetics of hematopoiesis in long-term marrow cultures from patients with acute myelogenous leukemia. Leukemia & Lymphoma 2002; 43: 2383–2390
   PubMed Web of Science ®Google Scholar
• Wognum A W, Eaves A C, Thomas T E. Identification and isolation of hematopoietic stem cells. Archives of Medical Research 2003; 34: 461–475
   PubMed Web of Science ®Google Scholar
• Chávez-González M A, Rosas-Cabral A, Vela-Ojeda J, González J C, Mayani H. Severe functional alterations in vitro in CD34+ cell subpopulations from patients with chronic myeloid leukemia. Leukemia Research 2004; 28: 639–647
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Flores-Guzmán P, Flores-Figueroa E, Martínez-Jaramillo G, Mayani H. In vitro characterization of two lineage-negative, CD34+ cell-enriched hematopoietic cell populations from human UC cells. Cytotherapy 2005; 7: 334–344
   PubMed Web of Science ®Google Scholar
• Eaves C J, Cashman J D, Wolpe S D, Eaves A C. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein-1α, an inhibitor of primitive normal hematopoietic cells. Proceedings of the National Academy of Sciences (USA) 1993; 90: 12015–12019
   PubMed Web of Science ®Google Scholar
• Aggarwal B B. Signalling pathways of the TNF superfamily: a double-edged sword. Natural Reviews in Immunology 2003; 3: 745–756
   PubMed Web of Science ®Google Scholar
• Mayani H, Little M T, Dragowska W, Thornbury G, Lansdorp P M. Differential effects of the hematopoietic inhibitors MIP-1α, TGFβ and TNFα on cytokine induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Experimental Hematology 1995; 23: 422–427
   PubMed Web of Science ®Google Scholar
• Chang J, Morgenstern G, Deakin D, Testa N G, Dexter T M. The use of bone marrow cells grown in LTC for autologous BMT in acute myeloid leukemia: an update. Bone Marrow Transplant 1989; 4: 2–11
   Web of Science ®Google Scholar
• Hope K J, Jin L, Dick J E. Human acute myeloid leukemia stem cells. Archives of Medical Research 2003; 34: 507–514
   PubMed Web of Science ®Google Scholar
• Cascavilla N, Melillo L, Greco M, Carella A M, Arena G D, Matera R, et al. Acute myeloid leukemia with stem cells phenotype based on CD133/CD34/CD117 co-expression. Blood 2001; 98(supplement)453a
   Google Scholar
• Jordan C T. Unique molecular and cellular features of acute myelogenous leukemia stem cells. Leukemia 2002; 16: 559–562
   PubMed Web of Science ®Google Scholar
• Santini V, Gozzini A, Scappini B, Rossi Ferrini P. Maturation and apoptosis of primary human acute myeloblastic leukemia clls are determined by TNF-alpha exclusively through CD120A stimulation. Haematologica 1999; 84: 291–297
   PubMed Web of Science ®Google Scholar
• Quentmeier H, Reinhardt J, Zaborski M, Drexler H G. Granulocyte-macrophage colony-stimulating factor: inhibitor of tumor necrosis factor-induced apoptosis. Leukemia Research 2003; 27: 539–545
   PubMed Web of Science ®Google Scholar
• Beyne-Rauzy O, Recher C, Dastugue N, Demur C, Pottier G, Laurent G, et al. Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells. Oncogene 2004; 23: 7507–7516
   PubMed Web of Science ®Google Scholar
• Murohashi I, Yoshida K, Kishimoto K, Takahashi T, Wakao D, Jinnai I, et al. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells. Journal of Interferon & Cytokine Research 2002; 22: 335–341
   PubMed Web of Science ®Google Scholar